Skip to main content

Table 4 Cox regression analyses for 90-day mortality

From: Permissive fluid volume in adult patients undergoing extracorporeal membrane oxygenation treatment

CFB quartiles

Cardiovascular disease

Non-cardiovascular disease

Unadjusted

Adjusted*

Unadjusted

Adjusted*

HR (95% CI)

P value

HR (95% CI)

P value

HR (95% CI)

P value

HR (95% CI)

P value

Quartile 1

1.00 (reference)

 

1.00 (reference)

 

1.00 (reference)

 

1.00 (reference)

 

Quartile 2

1.17 (0.75–1.83)

0.496

1.27 (0.77–2.10)

0.342

0.84 (0.56–1.27)

0.407

0.79 (0.48–1.30)

0.345

Quartile 3

2.82 (1.88–4.23)

< 0.001

2.58 (1.62–4.11)

< 0.001

1.61 (1.11–2.34)

0.012

1.66 (1.06–2.59)

0.026

Quartile 4

2.24 (1.47–3.41)

< 0.001

2.11 (1.26–3.54)

0.004

1.37 (0.93–2.02)

0.108

1.69 (1.05–2.72)

0.030

  1. CFB Cumulative fluid balance
  2. *Adjusted for age, sex, Charlson comorbidity index, Acute Physiology and Chronic Health Evaluation II score, and propensity score
  3. Propensity score was obtained by logistic regression analysis with covariables body mass index, extracorporeal membrane oxygenation (ECMO) pump time, ECMO blood flow rate, albumin, total carbon dioxide, acute kidney injury stage
  4. The 27 (3.7%) patients who were lost to follow-up were treated as censored